Atossa Therapeutics, Inc.
Panjang

Long | ATOS | This is a rare opportunity

655
ATOS

1- It's at support level right now, consolidated for 2 weeks.
2- It had a direct offering of 50m$ 2 weeks ago, new Institutional investors joined the team, they already had public offering and they didn't need any cash, they have cash for 3-4 years of operational cost.
3- it has 2 products for waiting P2 approval, one if them halted in Feb, because the results were great but didn't published the official approval from FDA yet, (Expected in 2 weeks)
4- it has a cure for cancer, put money in this company is a good cause and RIO is insane,
5- Average of price target is 6.25$, it means 300% .
6- buy-out is one of the possible options, and I expect an average price of 11$, it should be happen before shareholder meeting (less than 2 month)

* these are my ideas and could be wrong 100%, but if it be right thanks me later. lol

Penafian

Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.